 Judith Gault
Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 3 | 2021 | 71 | 1.370 |
Why?
| | Microtubule-Associated Proteins | 3 | 2009 | 174 | 0.790 |
Why?
| | Schizophrenia | 5 | 2017 | 418 | 0.750 |
Why?
| | Essential Tremor | 1 | 2020 | 6 | 0.710 |
Why?
| | Proto-Oncogene Proteins | 3 | 2009 | 609 | 0.670 |
Why?
| | Thalamus | 1 | 2020 | 78 | 0.660 |
Why?
| | Evoked Potentials, Auditory | 2 | 2020 | 173 | 0.660 |
Why?
| | Corpus Striatum | 1 | 2020 | 124 | 0.640 |
Why?
| | Psychotic Disorders | 1 | 2020 | 123 | 0.630 |
Why?
| | Hemangioma, Cavernous, Central Nervous System | 4 | 2006 | 7 | 0.610 |
Why?
| | Intracranial Arteriovenous Malformations | 2 | 2009 | 51 | 0.380 |
Why?
| | Receptors, Nicotinic | 4 | 2009 | 273 | 0.350 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2009 | 174 | 0.320 |
Why?
| | Point Mutation | 1 | 2009 | 217 | 0.310 |
Why?
| | Cerebrovascular Disorders | 2 | 2006 | 82 | 0.290 |
Why?
| | Polymorphism, Single-Stranded Conformational | 2 | 2003 | 27 | 0.240 |
Why?
| | Germ-Line Mutation | 1 | 2005 | 131 | 0.230 |
Why?
| | Endothelial Cells | 1 | 2009 | 695 | 0.230 |
Why?
| | Gene Duplication | 1 | 2003 | 62 | 0.220 |
Why?
| | KRIT1 Protein | 3 | 2009 | 6 | 0.220 |
Why?
| | Membrane Proteins | 1 | 2009 | 1024 | 0.220 |
Why?
| | Genetic Linkage | 1 | 2003 | 297 | 0.210 |
Why?
| | Chromosomes, Human, Pair 15 | 4 | 2009 | 53 | 0.200 |
Why?
| | Tic Disorders | 1 | 2021 | 7 | 0.190 |
Why?
| | Fluvoxamine | 1 | 2021 | 12 | 0.190 |
Why?
| | Serotonin Antagonists | 1 | 2021 | 30 | 0.190 |
Why?
| | Risperidone | 1 | 2021 | 26 | 0.190 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2021 | 32 | 0.190 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2021 | 38 | 0.180 |
Why?
| | Hemorrhage | 1 | 2005 | 618 | 0.180 |
Why?
| | DNA Mutational Analysis | 4 | 2009 | 372 | 0.170 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2006 | 1918 | 0.170 |
Why?
| | Autistic Disorder | 1 | 2021 | 163 | 0.160 |
Why?
| | Neural Pathways | 1 | 2020 | 260 | 0.150 |
Why?
| | Depressive Disorder, Major | 1 | 2021 | 304 | 0.150 |
Why?
| | Risk Assessment | 1 | 2006 | 2987 | 0.150 |
Why?
| | Brain | 3 | 2006 | 2370 | 0.140 |
Why?
| | Genotype | 4 | 2009 | 1786 | 0.130 |
Why?
| | Exons | 2 | 2005 | 300 | 0.110 |
Why?
| | Sequence Analysis, DNA | 3 | 2005 | 732 | 0.110 |
Why?
| | Base Sequence | 3 | 2009 | 2114 | 0.110 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 4 | 2009 | 96 | 0.100 |
Why?
| | Humans | 15 | 2021 | 115587 | 0.090 |
Why?
| | Molecular Sequence Data | 2 | 2005 | 2790 | 0.080 |
Why?
| | Middle Aged | 4 | 2020 | 26999 | 0.080 |
Why?
| | Sequence Deletion | 1 | 2009 | 167 | 0.080 |
Why?
| | Promoter Regions, Genetic | 2 | 2003 | 1122 | 0.080 |
Why?
| | Genetic Variation | 2 | 2003 | 877 | 0.080 |
Why?
| | Gene Expression | 2 | 2004 | 1435 | 0.080 |
Why?
| | Gene Frequency | 1 | 2009 | 485 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 3 | 2009 | 3069 | 0.070 |
Why?
| | Male | 7 | 2021 | 55949 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 930 | 0.070 |
Why?
| | Dementia, Vascular | 1 | 2006 | 17 | 0.070 |
Why?
| | Central Nervous System Cysts | 1 | 2006 | 12 | 0.070 |
Why?
| | Genetic Markers | 2 | 2005 | 325 | 0.070 |
Why?
| | Alleles | 2 | 2009 | 794 | 0.070 |
Why?
| | Cerebral Arteries | 1 | 2006 | 55 | 0.070 |
Why?
| | Heterozygote | 1 | 2006 | 252 | 0.070 |
Why?
| | Brain Neoplasms | 2 | 2004 | 980 | 0.070 |
Why?
| | Female | 6 | 2020 | 59913 | 0.060 |
Why?
| | Spinal Cord Neoplasms | 1 | 2004 | 40 | 0.060 |
Why?
| | Calcinosis | 1 | 2006 | 242 | 0.060 |
Why?
| | Genetic Testing | 1 | 2006 | 382 | 0.060 |
Why?
| | Central Nervous System Vascular Malformations | 1 | 2004 | 23 | 0.060 |
Why?
| | Gene Deletion | 1 | 2005 | 355 | 0.050 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2005 | 477 | 0.050 |
Why?
| | Hemangioma, Cavernous | 1 | 2003 | 15 | 0.050 |
Why?
| | Central Nervous System Neoplasms | 1 | 2004 | 125 | 0.050 |
Why?
| | Introns | 1 | 2003 | 226 | 0.050 |
Why?
| | Aged | 2 | 2020 | 19251 | 0.050 |
Why?
| | Family | 1 | 2006 | 594 | 0.050 |
Why?
| | Neovascularization, Pathologic | 1 | 2004 | 283 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2004 | 350 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 2 | 2009 | 2125 | 0.050 |
Why?
| | Neural Inhibition | 1 | 2002 | 152 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2005 | 2000 | 0.050 |
Why?
| | Prevalence | 1 | 2006 | 2264 | 0.050 |
Why?
| | Linkage Disequilibrium | 1 | 2001 | 247 | 0.040 |
Why?
| | RNA | 1 | 2005 | 819 | 0.040 |
Why?
| | Mutation | 2 | 2006 | 3364 | 0.040 |
Why?
| | Adult | 5 | 2021 | 30718 | 0.040 |
Why?
| | Colorado | 1 | 2006 | 4113 | 0.040 |
Why?
| | Stroke | 1 | 2005 | 1016 | 0.030 |
Why?
| | Patient Care Team | 1 | 2021 | 521 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1473 | 0.030 |
Why?
| | Child, Preschool | 1 | 2009 | 9133 | 0.030 |
Why?
| | Signal Transduction | 2 | 2004 | 4541 | 0.030 |
Why?
| | Risk Factors | 1 | 2006 | 8697 | 0.030 |
Why?
| | Adolescent | 2 | 2009 | 17889 | 0.030 |
Why?
| | Polymorphism, Genetic | 2 | 2009 | 621 | 0.030 |
Why?
| | Blotting, Southern | 1 | 2009 | 66 | 0.020 |
Why?
| | Gene Dosage | 1 | 2009 | 129 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2009 | 310 | 0.020 |
Why?
| | Headache Disorders | 1 | 2006 | 12 | 0.020 |
Why?
| | Vasculitis, Central Nervous System | 1 | 2006 | 17 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2006 | 79 | 0.020 |
Why?
| | Intracranial Hemorrhages | 1 | 2006 | 76 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2006 | 286 | 0.020 |
Why?
| | Patient Selection | 1 | 2009 | 654 | 0.020 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2004 | 65 | 0.010 |
Why?
| | Angiopoietins | 1 | 2004 | 13 | 0.010 |
Why?
| | Telangiectasia, Hereditary Hemorrhagic | 1 | 2004 | 10 | 0.010 |
Why?
| | Hepatocyte Growth Factor | 1 | 2004 | 33 | 0.010 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2004 | 82 | 0.010 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2004 | 83 | 0.010 |
Why?
| | Genetic Counseling | 1 | 2004 | 67 | 0.010 |
Why?
| | Anti-Inflammatory Agents | 1 | 2006 | 448 | 0.010 |
Why?
| | Auditory Perceptual Disorders | 1 | 2002 | 8 | 0.010 |
Why?
| | Corpus Callosum | 1 | 2003 | 57 | 0.010 |
Why?
| | Temporal Lobe | 1 | 2003 | 80 | 0.010 |
Why?
| | Temporal Arteries | 1 | 2003 | 47 | 0.010 |
Why?
| | Anticoagulants | 1 | 2006 | 549 | 0.010 |
Why?
| | Schizophrenic Psychology | 1 | 2002 | 86 | 0.010 |
Why?
| | Genetic Therapy | 1 | 2004 | 260 | 0.010 |
Why?
| | Frontal Lobe | 1 | 2003 | 139 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2002 | 489 | 0.010 |
Why?
| | Transforming Growth Factor beta | 1 | 2004 | 446 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2004 | 503 | 0.010 |
Why?
| | Lymphocytes | 1 | 2002 | 344 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 746 | 0.010 |
Why?
| | Down-Regulation | 1 | 2003 | 601 | 0.010 |
Why?
| | Up-Regulation | 1 | 2003 | 820 | 0.010 |
Why?
| | Disease Progression | 1 | 2006 | 2418 | 0.010 |
Why?
| | Pedigree | 1 | 2001 | 467 | 0.010 |
Why?
| | Phenotype | 1 | 2004 | 2829 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2003 | 2574 | 0.010 |
Why?
| | Child | 1 | 2003 | 18488 | 0.000 |
Why?
|
|
Gault's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|